News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ex-Stryker Corporation  (SYK) CEO MacMillan Headed to Johnson & Johnson (JNJ)'s Synthes, Inc. (SYST) Unit?



6/14/2012 9:27:30 AM

Former Stryker Corp. CEO Stephen MacMillan sure looks like a fit for Johnson & Johnson's medical device arm, now that a $21.3 billion Synthes buyout is slated to close tomorrow - but will a two-year non-compete stand in the way? As the completion of the union between Synthes Inc. and Johnson & Johnson (NYSE:JNJ) draws near, there's an awfully good executive sitting on the sidelines: former Stryker (NYSE:SYK) CEO Stephen MacMillan. Rumors are a-swirl that MacMillan, whose hasty exit from the Kalamazoo, Mich.-based orthopedic company earlier this year was precipitated by a personal relationship with a fellow employee, has been angling for a senior management position at the New Brunswick, N.J.-based healthcare conglomerate. He'd seemingly be a great fit to run the now vastly expanded orthopedic operation at Johnson & Johnson, which is fixing to pay a $21.3 billion dowry for Synthes and its orthopedic trauma business.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES